[Notes]
*The coverage of environmental accounting includes the Head Office Plant of Mochida Pharmaceutical Plant Co., Ltd.
*The coverage of social data is non-consolidated.
*The coverage of governance data is non-consolidated.
Environment
| Category | Coverage*1 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| CO2 emissions*2 | |||||
| Total（t-CO2） | a,b,c,d | 15,142 | 12,956 | 11,353 | |
| - Plants and research centers（t-CO2） | 12,868 | 10,690 | 9,196 | ||
| - Office（t-CO2） | 460 | 401 | 385 | ||
| - Commercial fleet（t-CO2） | 1,814 | 1,865 | 1,772 | ||
| CO2 emissions by Scope*3 | |||||
| Scope 1（t-CO2） | a,b,c | 4,017 | 4,350 | 4,256 | |
| Scope 2（t-CO2） | 9,311 | 6,742 | 5,325 | ||
| Scope 3（t-CO2） | - | 186,435 | 168,976 | 197,311 | |
| - Category 1：Purchased goods and services（t-CO2） | 177,614 | 159,554 | 187,098 | ||
| - Category 2：Capital goods（t-CO2） | 3,634 | 4,401 | 5,128 | ||
| - Category 3: Fuel- and energy-related activities not included in Scope 1 or Scope 2（t-CO2） | Not applicable | ||||
| - Category 4：Upstream transportation and distribution（t-CO2）*4 | - | - | - | ||
| - Category 5：Waste generated in operations（t-CO2） | 338 | 316 | 343 | ||
| - Category 6：Business travel（t-CO2） | 2,077 | 1,880 | 2,098 | ||
| - Category 7：Employee commuting（t-CO2） | 700 | 699 | 587 | ||
| - Category 8：Upstream leased assets（t-CO2） | 1,814 | 1,865 | 1,772 | ||
| - Category 9：Downstream transportation and distribution（t-CO2）*4 | - | - | - | ||
| - Category 10：Processing of sold products（t-CO2） | Not applicable | ||||
| - Category 11：Use of sold products（t-CO2） | Not applicable | ||||
| - Category 12：End-of-life treatment of sold products（t-CO2） | 258 | 261 | 285 | ||
| - Category 13：Downstream leased assets（t-CO2） | Not applicable | ||||
| - Category 14：Franchises（t-CO2） | Not applicable | ||||
| - Category 15：Investments（t-CO2） | Not applicable | ||||
| Energy | |||||
| Total（GJ） | a,b,c,d | 347,617 | 317,249 | 311,354 | |
| - Electric power purchased（GJ） | 235,290 | 204,879 | 201,630 | ||
| - Heavy oil A（GJ） | 0 | 0 | 0 | ||
| - Gasoline（GJ） | 27,029 | 27,207 | 25,846 | ||
| - LNG（GJ） | 63,692 | 65,363 | 65,821 | ||
| - City gas（GJ） | 21,579 | 19,786 | 18,043 | ||
| - LPG（GJ） | 27 | 15 | 14 | ||
| - Steam（GJ） | 0 | 0 | 0 | ||
| Water resources*5 | |||||
| Water consumption（Thousand m3） | a,b,c | 306 | 347 | 373 | |
| - Groundwater（Thousand m3） | 301 | 342 | 368 | ||
| - Public water（Thousand m3） | 5 | 5 | 5 | ||
| Amount of wastewater（Thousand m3） | 306 | 321 | 319 | ||
| - Sewerage（Thousand m3） | 15 | 10 | 10 | ||
| - Other（Thousand m3） | 291 | 311 | 309 | ||
| Water pollution*5 | |||||
| BOD emissions（t） | a,b,c | 0.5 | 0.4 | 1.5 | |
| COD emissions（t） | 0.4 | 0.4 | 0.5 | ||
| SS emissions（t） | 0.5 | 0.4 | 0.7 | ||
| Waste*5 | |||||
| Waste generated（t） | a,b,c | 533 | 511 | 500 | |
| External recycled waste（t） | 529 | 507 | 495 | ||
| External recycled waste rate（%） | 99.3 | 99.2 | 99.0 | ||
| Final disposal（t） | 4 | 4 | 5 | ||
| Final disposal rate（%） | 0.75 | 0.78 | 1.04 | ||
| OA paper（Ten thousand sheets） | 1,103 | 929 | 922 | ||
| Air pollution | |||||
| Particulate matter emissions（t） | a,b,c | 0 | 0 | 0 | |
| SOx emissions（t） | 0 | 0 | 0 | ||
| NOx emissions（t） | 0 | 0 | 0 | ||
| PRTR discharge*6 | |||||
| Handled amount（t） | a,b,c | 0.2 | 0.4 | 0.5 | |
| Released into the atmosphere*7（t） | 0 | 0 | 0 | ||
| Released into water*7（t） | 0 | 0 | 0 | ||
| Transferred to sewerage*7（t） | 0 | 0 | 0 | ||
| Transferred to waste（t） | 0.2 | 0.4 | 0.5 | ||
| Containers and package | |||||
| Container and package recycling（t） | a,c | 129 | 138 | 148 | |
| Environmental laws | |||||
| Number of violation（Cases） | a,b,c,d | 0 | 0 | 0 | |
*1
a.Mochida Pharmaceutical Co., Ltd.
b.Head Office Plant of Mochida Pharmaceutical Plant Co., Ltd.
c.Saitama Plant of Mochida Pharmaceutical Plant Co., Ltd.
d.Commercial fleet.
*2 The CO2 emissions from electricity will be calculated using the adjusted emission factor.
*3 The CO2 emissions per scope by the GHG protocol.
*4 Not calculated due to difficulties in obtaining the necessary data at this time.
*5 The branches and sales offices of Mochida Pharmaceutical Co., Ltd. are not included.
*6 Not includes branches and sales offices of Mochida Pharmaceutical Co., Ltd., because not applicable.
*7 <1t.
Environmental accounting
Units：Thousand JPY
| Category | FY2025 Investments | FY2025 Expenses | |
|---|---|---|---|
| Environmental conservation costs*8 | |||
| Costs within our business areas | 47,757 | 72,473 | |
| - Pollution prevention costs | 0 | 54,924 | |
| - Global environmental conservation costs | 47,757 | 1,207 | |
| - Resource recycling costs | 0 | 16,342 | |
| Upstream & downstream costs | 0 | 3,471 | |
| Environmental management costs | 0 | 18,157 | |
| Environmental R&D costs | 0 | 0 | |
| Social activity costs | 5,480 | 581 | |
| Environmental remediation costs | 0 | 0 | |
| Total | 53,237 | 94,682 | |
| Category | FY2024 | FY2025 | Y o Y | |
|---|---|---|---|---|
| Environmental conservation benefits | ||||
| CO2 emissions（t-CO2） | 7,118 | 6,496 | -622 | |
| Electricity usage（Thousand kWh） | 15,308 | 15,054 | -254 | |
| Heavy oil usage（kL） | 0 | 0 | 0 | |
| LNG usage（t） | 1,195 | 1,203 | 8 | |
| Water consumption（Thousand m3） | 238 | 253 | 15 | |
| Water discharge for public waters（Thousand m3） | 248 | 242 | -6 | |
| Waste generated（t） | 315 | 332 | 17 | |
*8 Include the cost for enviromental conservation;
Partially include the cost for multiple purpose, in the proportion for environment-purpose;
Exclude the depreciation expense for fixed asset.
Social
| Category | FY2023 | FY2024 | FY2025 | ||
|---|---|---|---|---|---|
| Employees information | |||||
| Number of employees（Consolidated）（Persons） | 1,522 | 1,508 | 1,479 | ||
| Number of employees（Persons） | 1,247 | 1,237 | 1,195 | ||
| - Female（Persons） | 385 | 391 | 379 | ||
| Number of managers（Persons） | 294 | 322 | 335 | ||
| - Female（Persons） | 34 | 38 | 41 | ||
| Ratio of female managers（%） | 11.6 | 11.8 | 12.4 | ||
| - Target*9（%） | 12.0 | 12.0 | 20.0 | ||
| Number of new recruits（Persons） | 34 | 34 | 33 | ||
| - Female（Persons） | 18 | 16 | 17 | ||
| Number of mid-career hires（Persons） | 33 | 37 | 40 | ||
| - Female（Persons） | 9 | 9 | 11 | ||
| Ratio of mid-career hires（%） | 49.3 | 52.1 | 54.8 | ||
| Ratio of disabled employees*10（%） | 2.4 | 2.53 | 2.57 | ||
| Average age（Years） | 42.8 | 43.3 | 43.1 | ||
| Average years of service（Years） | 16.9 | 17.0 | 16.5 | ||
| - Male（Years） | 17.8 | 17.9 | 17.3 | ||
| - Female（Years） | 15.0 | 15.0 | 14.6 | ||
| Difference in average years of service between male and female（Years） | 2.8 | 2.9 | 2.7 | ||
| Average annual salary（JPY） | 8,223,301 | 8,251,926 | 8,425,359 | ||
| Gender pay gap*11 All workers（%） | 70.5 | 69.7 | 71.2 | ||
| - Regular workers （%） | 72.0 | 70.9 | 73.0 | ||
| - Part-time and fixed-term workers（%） | 54.6 | 62.7 | 60.7 | ||
| Human resources development | |||||
| Retention rate after 3 years（%） | 86.8 | 97.3 | 97.1 | ||
| Staff turnover rate*12（%） | 3.2 | 4.5 | 5.1 | ||
| Work-life balance | |||||
| Number of employees who took holidays before and after childbirth leave（Persons） | 19 | 13 | 20 | ||
| Number of employees who took childcare leave（Persons） | 48 | 38 | 51 | ||
| - Female（Persons） | 20 | 17 | 16 | ||
| Ratio of male employees who took childcare leave（%） | 76.9 | 77.7 | 87.5 | ||
| Ratio of female employees who took childcare leave（%） | 100 | 100 | 100 | ||
| Number of employees using short-time work for childcare（Persons） | 36 | 43 | 43 | ||
| Ratio of returning to work after childcare leave（%） | 100 | 94.4 | 92.3 | ||
| Occupational health and safety | |||||
| Number of days of paid leave granted（Days） | 19.2 | 19.2 | 19.1 | ||
| Average usage of paid leave（Days） | 12.8 | 12.2 | 12.1 | ||
| Ratio of paid leave acquisition（%） | 66.8 | 63.6 | 63.6 | ||
| Average actual hours worked per year（Hours） | 2,013 | 2,011 | 2,029 | ||
| Average overtime hours per month（Hours） | 5.9 | 6.3 | 7.5 | ||
| Accident frequency rate*13 | 0.33 | 0 | 0 | ||
| Employee stock ownership association | |||||
| Number of members（Consolidated）（Persons） | 583 | 567 | 555 | ||
| Labor union | |||||
| Number of members（Consolidated）（Persons） | 986 | 962 | 933 | ||
| Donations | |||||
| Academic Research Grants, etc.*14（Million JPY） | 238 | 253 | - | ||
*9 FY2023 and FY2024 are measured against the targets for the end of FY2025, while FY2025 is measured against the targets for the end of FY2030.
*10 FY2025 figures are reported on a consolidated basis.
*11 Ratio of the average annual salary of female employees to the average annual salary of male employees.
*12 Except for retired and a loan employee.
*13 Number of deaths and injuries by Industrial accident／Total number of actual working hours×1,000,000.
*14 Except for Conference co-sponsorship fee.
Governance
| Category | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|
| Board of Directors | ||||
| Number of the Board（Persons） | 11 | 11 | 11 | |
| - Outside members（Persons） | 4 | 4 | 4 | |
| - Female members（Persons） | 1 | 1 | 2 | |
| Audit & Supervisory Board | ||||
| Number of Audit & Supervisory Board members （Persons） | 5 | 5 | 5 | |
| - Outside members（Persons） | 3 | 3 | 3 | |
| - Female members（Persons） | 1 | 1 | 1 | |
| Remuneration | ||||
| - Total Directors' remuneration （Million JPY） | 272 | 304 | 320 | |
| - Total Audit & Supervisory Board members' remuneration（Million JPY） | 65 | 64 | 67 | |
| Nomination and Compensation Advisory Committee | ||||
| Ratio of Independent board member（%） | 66.6 | 66.6 | 66.6 | |
| Meeting frequency | ||||
| Board of Directors（Times） | 14 | 14 | 14 | |
| Audit & Supervisory Board（Times） | 16 | 16 | 17 | |
| Compliance (Consolidated) | ||||
| Number of serious non-compliance incidents*15（cases） | 0 | 0 | 0 | |
| Awareness of hotline （%） | 98 | 98 | 97 | |
| Number of reports and consultations（cases） | 28 | 37 | 33 | |
*15 Incidents that have a significant impact on the Group's sales and profits or that are considered necessary to be disclosed outside the company.